ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk launches anti-diabetes pill semaglutide in India
Novo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
Announcement as on 20 January 2022

Novo Nordisk strikes .3 billion deal to buy research partner Dicerna Pharmaceuticals
Novo Nordisk said it's buying Dicerna Pharmaceuticals for .3 billion, or .25 per share in cash. Dicerna ended Wednesday at .28. Novo Nordisk already had a research collaboration with Dicerna, and said the deal is part of a strategy of using a bro
Announcement as on 18 November 2021

Prothena sells amyloidosis portfolio to Novo Nordisk for up to .2 billion
Shares of Prothena Corp. Plc were up 1.3% in premarket trading on Monday after the company announced a deal to sell its ATTR amyloidosis portfolio to Novo Nordisk in a 0 million deal that is worth up to .2 billion, based on milestones. ATTR amyloidos
Announcement as on 12 July 2021

Prothena sells ATTR amyloidosis portfolio to Novo Nordisk for up to .2 billion
Shares of Prothena Corp. Plc were up 1.3% in premarket trading on Monday after the company announced a deal to sell its ATTR amyloidosis portfolio to Novo Nordisk in a 0 million deal that is worth up to .2 billion, based on milestones. ATTR amyloido
Announcement as on 12 July 2021

European stocks rise on upbeat forecasts from Pandora, Novo Nordisk
Danish jewellery maker Pandora jumped 10.6% and German online fashion company Zalando rose 3.7% after raising their outlook for 2020 on the back of a strong third quarter.
Announcement as on 09 October 2020

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 42.38
  • 12Day Average: 43.64
  • 20Day Average: 44.31
  • 50Day Average: 42.18
  • 100Day Average: 44.03
  • 150Day Average: 46.13
  • 200Day Average: 48.57

NVO Indicators & signals

Indicator MACD (12,26,9)

43.27, 43.47, 0.3
Indicator MACD is in negative zone

Indicator ADX (14)

18.84, 17.18, 25.15
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Tue Jun 2026 42.20 41.06 to 42.31 2.9% 1.07 times
08 Mon Jun 2026 41.01 41.00 to 43.49 -4.52% 1.46 times
05 Fri Jun 2026 42.95 42.86 to 44.37 -1.81% 0.8 times
04 Thu Jun 2026 43.74 41.92 to 44.37 4.12% 1.07 times
03 Wed Jun 2026 42.01 41.90 to 43.63 -2.1% 0.81 times
02 Tue Jun 2026 42.91 42.25 to 44.39 -2.63% 1.24 times
01 Mon Jun 2026 44.07 43.79 to 45.39 -3.29% 0.93 times
29 Fri May 2026 45.57 45.15 to 46.32 0.13% 0.78 times
28 Thu May 2026 45.51 43.95 to 46.05 2.13% 1.36 times
27 Wed May 2026 44.56 44.05 to 45.23 0.81% 0.86 times
26 Tue May 2026 44.20 44.18 to 45.48 -1.67% 0.69 times
22 Fri May 2026 44.95 43.72 to 45.18 1.26% 0.77 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top